Mission Statement

Cholangiocarcinoma-UK, an affiliate of the British Association for Study of Liver Disease (BASL), is a multi-disciplinary Special Interest Group (SIG) of clinicians, scientists and patient advocates whose purpose is to facilitate collaborative research, enhance service development and raise awareness of Cholangiocarcinoma. 

 Aims of Cholangiocarcinoma UK

•        Be the recognised leading authority on Cholangiocarcinoma in the UK

•        Become affiliated to other relevant major national organisations e.g. BASO, BSG

•        Facilitate basic science and clinical research as well as sample collection, including for biomarker development

•        Improve the pathway to collaborative clinical trials and opportunities for research funding

•        Update national guidelines and advise on policy and best practice

•        Optimise and standardise clinical management across the country

•        Monitor epidemiological trends accurately.

Resources

Annual reports

Annual report 2018-19 -  Download Annual report_2018-19_CCA-UK.pdf.

 

1st meeting - 7 December 2018

Report - Download BASL_BSG report_Summary_Outcomes_CCA-UK Meeting 7 Dec 2018_FINAL.pdf.

Welcome presentation, Shahid Khan, St Mary’s Hospital, London - Download Welcome.pdf

Presentation on the patient/healthcare professional partnership, Helen Morement, AMMF -  Download The patient_healthcare professional partnership.pdf

Presentation on Epidemiology and aetiology: What we don’t know & how can we find out, Shahid Khan, St Mary’s Hospital, London -  Download Epidemiology and aetiology_What we dont know and how we can find out.pdf

Presentation on Ensuring quality: Centres of “excellence/expertise”?, Hassan Malik, Aintree University Hospital Download Ensuring quality_Centres of excellence and expertise.pdf

Presentation on Medical oncology: The unmet needs and how we meet them, John Bridgewater, UCL & Juan Valle, Christie NHS Foundation Trust -  Download Medical oncology_The unmet needs and how we meet them.pdf

Presentation on Clinical oncology: Establishing novel roles in CCA therapy, Maria Hawkins, University of Oxford -  Download Clinical oncology_Establishing novel roles in CCA therapy.pdf

 

Patient representation

The AMMF is represented on the CCA-UK Steering Committee and is the UK’s only cholangiocarcinoma charity - http://ammf.org.uk/

 

Global CCA Alliance

The Global Cholangiocarcinoma Alliance (GCA) has united to establish a global voice in CCA through community collaborations. The GCA has a shared vision to raise the awareness of CCA, in order to improve prevention, survival and the quality of life of CCA patients globally.  CCA-UK is a partner in this Alliance. For more information, visit https://globalccaalliance.com/en

Latest News

Register for the CCA-UK annual meeting 

Date: 14 November 2019

Venue: Jubilee Conference Centre, University of Nottingham

This year CCA-UK annual meeting will have a basic science theme. A full programme is planned, featuring a series of invited speakers and talks from abstracts. There will also be a moderated round table discussion on key questions in the basic science of Cholangiocarcinoma and where next. This year will also see the inauguration of the Neil Blenkinsop Memorial Lecture, to be given by Dr Chiara Braconi of the University of Glasgow. Lunch will be provided alongside viewing of posters.

Early registration costs just £50 or £25 for trainees/students until 14 October 2019. The same deadline applies for abstract submission. Click here to reserve your place and for guidance on abstract submission.

Download CCA-UK Leaflet.pdf

Download Programme_v0.3.docx.

 

Follow CCA-UK on Twitter - @ccaukgroup

The Cholangiocarcinoma-UK Committee

Chair Shahid Khan, Imperial College London
Secretary Derek Manas, Freeman Hospital, Newcastle upon Tyne
Basic science  David Bates, University of Nottingham; Chiara Braconi, University of Glasgow
Clinical oncology  Maria Hawkins, University of Oxford
Endoscopy Steve Pereira, University College London
Hepatology Simon Rushbrook, Norfolk & Norwich Hospital
Medical oncology  Chiara Braconi, University of Glasgow; John Bridgewater, University College London; Juan Valle, University of Manchester 
Pathology Tim Kendall, University of Edinburgh
Patient advocate  Helen Morement, AMMF
Surgery  Hassan Malik, Aintree University Hospital, Liverpool; Nigel Heaton, Kings College London
Trainee representatives  Pilar Acedo, University College London; Leonard Marc Quinn, University of Liverpool

Join Basl - BASL Membership covers membership to BASL and all of it's sub-groups: BLNA, BVHG, BLTG, BHPG and HCC-UK. Click here to find out more. BASL 2019 - The BASL Annual Meeting is the highlight of the BASL calendar and the main liver meeting in the UK. Strathclyde University, Glasgow, 18th - 20th September 2019 BASL Events - BASL and the BASL Sub Groups run an exciting and varied calendar of educational events throughout the year, as well as endorsing other not to miss events. Click here to Book Now.